New research on fungi suggests they could be demonstrating some form of intelligence, but not all experts are convinced.
Get the latest international news and world events from around the world.
Mining the Moon begins: US firm’s robot to extract rare helium-3 and launch payloads back to Earth for futuristic energy use
In a bold move that could transform the future of clean energy and quantum computing, a Seattle-based startup, Interlune, is taking the first steps toward mining the Moon for a rare isotope called helium-3. This new venture has the potential to challenge the boundaries of technology, as well as the frameworks for space exploration and international resource management.
High-tech company makes key breakthrough that could revolutionize smartphones and EVs: ‘A pivotal commercial milestone’
A USA company is producing nano-sulfide solid-electrolyte powders for use in batteries.
Diabetes drug cuts migraines in half by targeting brain pressure
A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic migraines who took liraglutide, a GLP-1 receptor agonist, experienced over 50% fewer headache days and significantly improved daily functioning without meaningful weight loss. Researchers believe the drugs ability to lower brain fluid pressure is the key, potentially opening a completely new way to treat migraines. The effects were fast, sustained, and came with only mild side effects.
A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new study presented today at the European Academy of Neurology (EAN) Congress 2025.
Researchers at the Headache Center of the University of Naples “Federico II” gave the glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide to 26 adults with obesity and chronic migraine (defined as ≥15 headache days per month). Patients reported an average of 11 fewer headache days per month, while disability scores on the Migraine Disability Assessment Test dropped by 35 points, indicating a clinically meaningful improvement in work, study, and social functioning.
Scientists reverse Parkinson’s symptoms in mice — Could humans be next?
Scientists at the University of Sydney have uncovered a malfunctioning version of the SOD1 protein that clumps inside brain cells and fuels Parkinson’s disease. In mouse models, restoring the protein’s function with a targeted copper supplement dramatically rescued movement, hinting at a future therapy that could slow or halt the disease in people.
Why Different Neuron Parts Learn Differently?
To try everything Brilliant has to offer—free—for a full 30 days, visit https://brilliant.org/ArtemKirsanov. You’ll also get 20% off an annual premium subscription.
Socials:
X/Twitter: https://twitter.com/ArtemKRSV
Patreon: https://patreon.com/artemkirsanov.
My name is Artem, I’m a graduate student at NYU Center for Neural Science and researcher at Flatiron Institute. In this video we explore a recent study published in Science, which revealed that different compartments of pyramidal neurons (apical vs basal dendrites) use different plasticity rules for learning.
Link to the paper:
https://www.science.org/doi/10.1126/science.ads4706
Outline:
00:00 Introduction.
01:23 Synaptic transmission.
06:09 Molecular machinery of LTP
08:40 Hebbian plasticity.
11:21 Non-Hebbian plasticity.
12:51 Hypothesis.
14:42 Experimental methods.
17:10 Result: compartmentalized plasticity.
19:30 Interpretation.
22:01 Brilliant.
23:08 Outro.
Music by Artlist.
“We Might Be Seeing a New Force”: Physicists Detect Possible Fifth Law of Nature Hidden Deep Inside Atomic Structures
IN A NUTSHELL 🔬 Physicists from Germany, Switzerland, and Australia have identified potential evidence of a mysterious fifth force within atoms. 📏 The discovery challenges the Standard Model of physics, which traditionally categorizes forces into four main types. 🧩 Researchers propose the existence of a hypothetical Yukawa particle that could mediate this new force within